#8 - Kimberly-Clark (NYSE:KMB)
At first glance, Kimberly-Clark (NYSE:KMB) may seem like an odd addition to this list. The company’s stock is barely registering a gain for the year. However, it is up over 25% since March. And that’s because the personal care products it produces have been in high demand.
The company does not appear to be getting a boost for its surgical and medical instruments as hospitals and clinics reopened for elective surgeries. That will be something to watch.
But with a stock like Kimberly-Clark, it’s important to remember your reason for owning the stock. In this case, it’s a dividend that has increased every year for the last 47 years. In an environment where many companies are cutting or suspending their dividends, Kimberly-Clark is continuing to provide that value for shareholders.
That may not be enough to get growth investors excited, but if more Americans choose to opt out of this soft recovery, KMB stock may be primed for some growth as well.
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Read More - Current Price
- $131.32
- Consensus Rating
- Hold
- Ratings Breakdown
- 6 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings.
- Consensus Price Target
- $149.93 (14.2% Upside)
